Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phenanthrene 9,10-oxide is a small organic molecule with the molecular formula C14H10O and a molecular weight of 194.23. It is an epoxide metabolite of phenanthrene, part of the polycyclic aromatic hydrocarbon (PAH) family. The compound has various systematic names and is sometimes referred to as 9,10-phenanthrene oxide, phenanthrene-9,10-epoxide, or 9,10-epoxy-9,10-dihydrophenanthrene[5][6]. This compound is chemically reactive and can form DNA adducts, contributing to carcinogenicity observed with PAHs, but it is not a receptor, enzyme, transporter, or conventional therapeutic target[5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phenanthrene 9,10-oxide.